Esmolol Hydrochloride Injection
Product Images NDC 51662-1427

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esmolol Hydrochloride (NDC 51662-1427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse (Adverse)

A table listing clinical trial adverse reactions for Esmolol Hydrochloride injection with frequency of 3% or greater. It categorizes reactions by system organ class, such as vascular disorders (e.g., asymptomatic hypotension 25%), general disorders (infusion site reactions 8%), gastrointestinal disorders (nausea 7%), and nervous system disorders (dizziness and somnolence, each 3%). Additional note details hypotension resolution during and after infusion.*

FDA Label Image

Description (Description)

A table titled 'BREVIBLOC Injection Formulations' listing three formulations of Esmolol Hydrochloride injection: BREVIBLOC PREMIXED 10 mg/mL, BREVIBLOC PREMIXED Double Strength 20 mg/mL, and BREVIBLOC Injection 10 mg/mL. It details the concentrations of Esmolol Hydrochloride and several excipients such as Sodium Chloride, Sodium Acetate Trihydrate, Glacial Acetic Acid, and pH adjustments by Sodium Hydroxide or Hydrochloric Acid, with volumes noted as quantities sufficient to specific volumes for each formulation.*

FDA Label Image

Dosage 1 (Dosage 1)

Table titled 'Table 1 Step-Wise Dosing' outlining dosing steps and actions for Esmolol Hydrochloride injection. It details a sequence of four steps describing optional loading doses and subsequent dose adjustments based on micrograms per kilogram per minute over specified time intervals.*

FDA Label Image

Dosage Forms (Dosage Forms)

A data table titled 'Table 2 BREVIBLOC Injection Presentations' listing three formulations of BREVIBLOC (Esmolol Hydrochloride). It details product names, total doses, concentrations of Esmolol Hydrochloride, and packaging types, including premixed injections in 250 mL and 100 mL bags, and an injection in a 10 mL vial.*

FDA Label Image

Dosage Image (Dosage Image)

An instructional diagram of an intravenous injection bag showing two ports at the bottom. The left port is labeled as the medication port for withdrawing the initial bolus only, and the right port is labeled as the delivery port for administering the medication.*

FDA Label Image

Bag Label (Inj Bag Label)

Label for Brevibloc Premixed Injection containing Esmolol Hydrochloride in Sodium Chloride at strength 10 mg/mL (2,500 mg/250 mL). The product is a 250 mL intravenous injection, provided by Baxter Healthcare Corporation, Deerfield, IL. The label notes no preservatives added, sterile nonpyrogenic solution, and storage instructions.*

FDA Label Image

Outer Packaging (Outer Packaging Resized)

Brevibloc Premixed Injection containing Esmolol Hydrochloride in Sodium Chloride at 10 mg/mL strength, provided in a 250 mL Iso-Osmotic intravenous solution. The label, from Baxter Healthcare Corporation, includes usage instructions, cautions, storage conditions, and states the product is sterile, nonpyrogenic, and for single intravenous use only.*

FDA Label Image

Serialized Bag Labeling (Seerialized Bag Labeling Resized)

Packaging label for Esmolol Hydrochloride Injection, 2.5 mg/mL in 250 mL, preserved-free, single intravenous use only. The label includes dosing, cautions, and storage instructions from Bayer Healthcare Corporation. Distributed by HF Acquisition Co. LLC, Mukilteo, WA. The packaging is a sealed, flexible plastic pouch with barcodes and lot information.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Esmolol Hydrochloride showing the molecular arrangement including a benzene ring linked to various functional groups and the hydrochloride (HCl) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.